Information from Press Conferences and Official Media

Federal Information

(22 de Noviembre de 2020)

Health Secretary

- When updating the national epidemiological traffic light, Dr. Cortés Alcalá, General Director of Health Promotion, reiterated that Nuevo León is at risk of changing to a red traffic light. León is at risk of changing to red traffic light, so he asked citizens to follow the guidelines and mitigation activities. mitigation.

- Regarding the effectiveness results announced by several pharmaceutical companies on the COVID-19 vaccine, Dr. José Luis Alomía, Director of Epidemiology, commented that there are still no official results of phase 3 of any vaccine. Alomía, Director of Epidemiology, commented that there are still no official phase 3 results for any of the vaccines. He noted that Once the results are officially published, they must be endorsed by the competent international authorities for certification. authorities for certification.

- Regarding the vaccination schedule that Mexico could follow, Dr. Alomía indicated that the vaccination schedule and program will be shared, as well as the logistics so that the population can be vaccinated. the vaccination schedule and program will be shared, as well as the logistics for the population to be vaccinated.

State Information

(22 de Noviembre de 2020)

Health Secretary

- The Secretary of Health, Dr. Manuel de la O, commented that in Nuevo Leon there is a treatment management protocol for diagnosed patients. patients diagnosed, he reiterated that so far there is no specialized treatment to combat the disease.

- He called on pre-candidates and political parties not to hold massive events and said that sanctions will be evaluated for candidates who do not comply with the protocol guidelines, which will be published in the coming weeks. for candidates who do not comply with the guidelines of the protocol that will be published in the coming weeks.

- Regarding the clinical trial to be carried out in the State, the Secretary of Health mentioned that the application of the vaccines will begin next week and that so far there are 550 candidates who have met the inclusion criteria. the vaccines and that so far there are 550 candidates who have met the inclusion criteria.

- Finally, when asked about the increase in cases during the last few weeks, Dr. de la O commented that it is due to the increased mobility and relaxation of measures by the population. mobility and relaxation of measures on the part of the population.

Number of cases

Economic Situation

Financial indicators

Main economic news

(23 de Noviembre de 2020)

- IMF ratifies Flexible Credit Line for Mexico and supports dollar liquidity. liquidity. The International Monetary Fund ratified this Friday that Mexico meets all of the necessary all the necessary eligibility criteria to access, if needed and without conditions, the resources of a flexible credit line and without any condition whatsoever, to access the resources of a flexible credit line granted in 2019 for a term of two years (two-year 2019 for a term of two years (El Economista). https://bit.ly/335xK6z

- Working poverty peaks in the third quarter of 2020. The National The National Council for the Evaluation of Social Development Policy indicated that this is due to the pandemic and its effects on the pandemic and its effects on employment (El Financiero). https://bit.ly/3nPWG9U

- Europe's economy will not improve to 2019 levels before 2022 because of the coronavirus, warns the ECB. Europe's GDP will not recover to its 2019 level until the autumn of 2022, predicted the European Central Bank's chief economist, Philip Lane (The Economist). https://bit.ly/2J7FJbV

World News

- Pfizer's vaccine could gain approval in the U.K. by the end of the week. week. Pfizer's Covid-19 vaccine could be approved in the UK by the end of the week, even before the formulation receives U.K. by the end of the week, even before the formulation receives regulatory approval in the U.S., The U.S. regulators, The Telegraph reported Sunday. Telegraph reported Sunday. https://bit.ly/3lX7Ads

- The first anti-COVID vaccinations in the U.S. could begin as early as Dec. 11. December 11. The United States could begin the first vaccinations against COVID-19 just 24 hours after receiving the COVID-19 vaccinations just 24 hours after receiving Food and Drug Administration (FDA) approval. Food and Drug Administration (FDA), which should kick off the largest immunization campaign in U.S. history. immunization campaign in the country's history in mid-December. https://reut.rs/3nM5621

- AstraZeneca: COVID-19 vaccine is "highly effective". AstraZeneca AstraZeneca announced Monday that late-stage trials of its vaccine developed with Oxford University against COVID-19 were "highly effective. developed with Oxford University against COVID-19 were "highly effective" in preventing the disease, giving effective" in preventing the disease, giving public health officials hope that they may soon have the public health officials hopeful that they may soon have access to a vaccine that is easier to distribute than some of its pharmaceutical rivals. https://bit.ly/3pSmAM8